Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 3000 LAKESIDE DR, BANNOCKBURN, IL
- Founded
- Not disclosed
📈 Company Timeline
Option Care Health, Inc. proxy and shareholder-vote filing
Option Care Health, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.
Option Care Health, Inc. proxy and shareholder-vote filing
Option Care Health, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.
Option Care Health, Inc. reported A material agreement
Option Care Health, Inc. filed an 8-K covering a material agreement, Regulation FD disclosure, supporting financial statements or exhibits.
Large-holder ownership filing
A holder reported or amended a beneficial ownership position of more than 5% in Option Care Health, Inc..
Option Care Health, Inc. filed Form 10-Q
Option Care Health, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
Capital Structure & Financial Position
Financial strength and liquidity analysisSource: SEC EDGAR company facts (opens in a new tab) Balance sheet dated
Peer Comparison - Health Care
| Company | Price | Market Cap |
|---|---|---|
| LLY - Eli Lilly and Company |
$1,276.13
Yahoo Finance |
$1.20T |
| JNJ - Johnson & Johnson |
$256.74
Yahoo Finance |
$618.71B |
| ABBV - AbbVie Inc. |
$284.80
Yahoo Finance |
$503.28B |
| UNH - UnitedHealth Group Incorporated |
$418.43
Yahoo Finance |
$375.58B |
| MRK - Merck & Co., Inc. |
$148.55
Yahoo Finance |
$366.50B |
📋 Corporate Actions
Recent and upcoming corporate eventsFinancials
Financial statements and key metrics analysis| Quarter | Revenue (USD) | Operating income | Net income | Diluted EPS (USD) | Filed |
|---|---|---|---|---|---|
| Q1 2026 | $1.35B | $72.55M | $45.34M | $0.29 | 10-Q · 30 Apr 2026 |
| Q4 2025 | $1.47B | $91.50M | $58.52M | Unavailable | 10-K · 24 Feb 2026 |
| Q3 2025 | $1.44B | $84.51M | $51.82M | $0.32 | 10-Q · 30 Oct 2025 |
| Q2 2025 | $1.42B | $82.71M | $50.52M | $0.31 | 10-Q · 30 Jul 2025 |
| Q1 2025 | $1.33B | $79.19M | $46.74M | $0.28 | 10-Q · 29 Apr 2025 |
| Q4 2024 | $1.35B | $87.04M | $60.11M | Unavailable | 10-K · 24 Feb 2026 |
Analyst Consensus
Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 23.00–33.00 Ratings are third-party opinions, not advice.
💰 Upcoming Dividends
Next dividend paymentsGuidance Evolution
💼 Director Transactions
Recent insider activityTop Shareholders
Source: Nasdaq institutional holdings (opens in a new tab) Observed · 3 hours ago